Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Nanosphere Test for Gram-positive Bacteria

NEW YORK (GenomeWeb News) – Nanosphere today said that it has received de novo clearance from the US Food and Drug Administration to market its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on its Verigene System.

The test detects the genus and species for a broad panel of clinically significant gram-positive bacteria, as well as several markers of antimicrobial resistance, including the mecA, vanA, and vanB genes, which confer resistance to methicillin/oxacillin and vancomycin, Nanosphere said. It added that the test can identify bacterial and antimicrobial resistance genes from gram-positive blood culture bottles within two-and-a-half hours, compared to the two to three days required by current microbiological methods.

The sample-to-result BC-GP test automates bacterial DNA extraction and target detection on the Verigene system.

"With the BC-GP test, patients suspected of deadly infections can now get a first-ever diagnostic tool for detecting disease-causing bacteria while simultaneously determining antibiotic resistance within the critical timeframe for making and adjusting initial treatment," Nanosphere CEO William Moffitt said in a statement.

The Northbrook, Ill.-based company added that it is developing a test for gram-negative blood cultures that will detect genus, species, and resistance on an automated platform. It also plans to submit a test for C. difficile and a panel of enteric bacterial and viral pathogens for FDA clearance this year.

Shares of Nanosphere closed up 21 percent at $2.32 in Wednesday trade on the Nasdaq.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.